Welcome to our dedicated page for UNIVERSAL INSURANCE HOLDINGS SEC filings (Ticker: UVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNIVERSAL INSURANCE HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNIVERSAL INSURANCE HOLDINGS's regulatory disclosures and financial reporting.
Universal Insurance Holdings, Inc. (UVE) director and officer reports tax withholding share disposition. A reporting person who serves as both a director and as CIO & CAO filed a Form 4 for a transaction dated December 16, 2025.
The filing shows that 406 shares of common stock were disposed of at $33.19 per share under transaction code "F", which indicates shares were withheld to cover taxes. An accompanying note explains these shares were withheld to satisfy tax withholding obligations related to the vesting of 1,666 restricted stock units (RSUs) on that date. Following the transaction, the insider beneficially owns 9,132 shares of Universal Insurance common stock, held directly.
Universal Insurance Holdings, Inc. reported an equity compensation grant to an executive. On December 5, 2025, the company awarded 3,500 restricted stock units (RSUs) tied to its common stock to its Principal Accounting Officer, who is an officer of the company and the sole reporting person on this filing. Each RSU represents a contingent right to receive one share of Universal Insurance common stock.
The RSUs vest in three approximately equal installments on each of the first three anniversaries of the grant date, starting from December 5, 2025, and require the executive to remain employed through each vesting date. This filing is a standard Form 4 disclosure, showing ongoing use of stock-based compensation to align executive interests with shareholders over time.
Universal Insurance Holdings, Inc. executive transaction: Executive Chairman and Director Sean P. Downes reported selling 20,000 shares of UVE common stock on 11/25/2025. The sale was executed at a weighted average price of $33.456 per share, with individual trade prices ranging from $33.19 to $33.82.
Following this transaction, he beneficially owns 1,263,512 shares directly, plus 2,000 shares held indirectly through his spouse and 18,000 shares held indirectly through his children. The filing notes that detailed trade breakdowns by price within the reported range are available upon request.
UVE has a Rule 144 notice covering the planned sale of 20,000 shares of common stock. The shares are to be sold through Raymond James & Associates on the NYSE, with an approximate sale date of 11/25/2025 and an aggregate market value of 678,800.00. The seller acquired 20,000 common shares on 11/06/2025 from the issuer as "Lieu Compensation," with cash listed as the nature of payment on the same date. Over the past three months, the same seller completed two additional sales of 20,000 common shares each, on 09/04/2025 and 10/29/2025, for gross proceeds of 505,958.05 and 627,062.05, respectively.
Universal Insurance Holdings, Inc. (UVE) director reported an open‑market sale of company stock. On 11/14/2025, the reporting person sold 24,308 shares of UVE common stock at a weighted average price of $34.5076 per share, with individual trade prices ranging from $34.03 to $34.83. After this transaction, the director beneficially owns 247,320 shares of UVE common stock held directly.
Universal Insurance Holdings (UVE): Form 144 notice of proposed sale. A holder filed to sell 24,308 common shares, with an aggregate market value of $839,598.32. The filing lists Raymond James & Associates as broker and indicates an approximate sale date of 11/14/2025 on the NYSE.
The shares listed for sale were acquired in lieu of compensation on two dates: 7,298 shares on 01/13/2020 and 17,010 shares on 01/22/2018. As context, 28,286,229 shares were outstanding at the time shown in the notice; this is a baseline figure, not the amount being offered. The filing also reports a recent sale activity: Jon Springer sold 35,435 common shares on 10/30/2025 for $1,111,302.98.
Universal Insurance Holdings (UVE) received a Schedule 13G from Donald Smith & Co., Inc. reporting beneficial ownership of 1,494,895 common shares, equal to 5.28%.
Donald Smith & Co. reports sole voting power over 1,370,582 shares and sole dispositive power over 1,480,322 shares; DSCO Value Fund, L.P. holds 14,573 shares with sole voting and dispositive power. The filing states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control. The date of event which requires filing is 09/30/2025.
Universal Insurance Holdings (UVE) declared a cash dividend of $0.29 per share, consisting of a regular quarterly dividend of $0.16 and a special dividend of $0.13. The dividend is payable on December 12, 2025 to shareholders of record as of December 5, 2025.
This brings total regular and special dividends declared in 2025 to $0.77 per share. The mix of a recurring quarterly dividend plus a special payout signals an additional return to shareholders beyond the regular distribution for the year.
Universal Insurance Holdings (UVE): insider transaction reported. Executive Chairman and Director Sean P. Downes sold 20,000 shares of common stock on 10/29/2025 at a weighted average price of $31.4034. The sale occurred in multiple trades within a price range of $30.84 to $31.71.
Following this transaction, Downes beneficially owns 1,283,512 shares directly. He also reports indirect holdings of 18,000 shares by children and 2,000 shares by spouse.
Universal Insurance Holdings (UVE) — insider transaction filed. A company director reported a sale of common stock on 10/30/2025. The filing shows a disposition of 35,435 shares coded “S” for sale at a weighted average price of $31.4119.
Following the transaction, the reporting person beneficially owns 271,628 shares, held directly. The shares were sold in multiple trades within a price range of $31.13 to $31.625, and detailed trade‑by‑trade information is available upon request as noted in the footnote.